SAN FRANCISCO--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) today announced that its Board of
Directors has elected Brad Lerman as a new independent director,
effective April 24, 2018. With the election of Mr. Lerman, the size of
McKesson’s Board of Directors increases from eight to nine members,
eight of whom are independent.
“With more than 25 years of experience bringing insights that bridge
compliance and government relations with corporate strategy, Brad will
be an immediate asset to McKesson’s Board of Directors,” said John H.
Hammergren, chairman and chief executive officer, McKesson. “His deep
understanding of the healthcare industry and experience in the public
and private sectors bring valuable insights to our Board. We have an
ongoing commitment to regularly refreshing and strengthening our Board,
and Brad is a perfect match for the background we were seeking in this
search process.”
“McKesson is a renowned industry leader and the Company possesses a
strong foundation for long-term growth. I look forward to working
collaboratively with my board colleagues to help guide the Company in
advancing its mission to deliver better health to all,” added Brad
Lerman.
McKesson regularly engages with its shareholders on corporate governance
matters such as board composition and refreshment. “Our director
selection process continues to equip the Board with the right mix of
qualifications, perspectives, and experiences. The addition of Brad
enhances our Board’s overall skill set and supports the execution of
McKesson’s strategy, which is designed to deliver long-term growth and
sustainable value creation for shareholders,” said Edward Mueller,
McKesson’s lead independent director.
Brad Lerman
Mr. Lerman, age 61, is senior vice president, general counsel and
corporate secretary for Medtronic. He leads the company’s global legal,
government affairs and ethics and compliance functions. Prior to
Medtronic, Brad served as executive vice president, general counsel and
corporate secretary for the Federal National Mortgage Association
(Fannie Mae) and as senior vice president, associate general counsel and
chief litigation counsel for Pfizer. For a decade, Mr. Lerman served as
a private practice attorney and litigation partner at Winston & Strawn
LLP in Chicago. Prior to private practice, he served as a federal
prosecutor for the U.S. Department of Justice, where he was an assistant
U.S. attorney in the Northern District of Illinois for eight years.
About McKesson Corporation
McKesson Corporation, currently ranked 5th on the FORTUNE
500, is a global leader in healthcare supply chain management solutions,
retail pharmacy, community oncology and specialty care, and healthcare
information technology. McKesson partners with pharmaceutical
manufacturers, providers, pharmacies, governments and other
organizations in healthcare to help provide the right medicines, medical
products and healthcare services to the right patients at the right
time, safely and cost-effectively. United by our ICARE shared
principles, our employees work every day to innovate and deliver
opportunities that make our customers and partners more successful — all
for the better health of patients. McKesson has been named the “Most
Admired Company” in the healthcare wholesaler category by FORTUNE, a
“Best
Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly
company by Military Friendly. For more information, visit www.mckesson.com.